Home Tampieri holding
    • EN
    • IT
Tampieri
  • EN
  • IT
  • Company
      • about us
      • goals and values
      • our story
      • our team
      • conditions of sale
      • code of ethics
      • certifications and policies
      • career
  • Products & Services
      • orthopaedic and spine surgery
      • neurosurgery
  • network
  • Case histories
  • Media
      • Video contents
      • Photo albums
      • Interviews
      • Press Kit
  • News
  • Contacts


  • previous news
  • back to the archive
  • next news
Recent clinical paper on CustomBone Service
03.08.23    Message intended for healthcare professionals only

Recent clinical paper on CustomBone Service

Message intended for healthcare professional only
We would like to inform you about a recent clinical paper con CustomBone Service

The paper titled “The Antibiotic Immersion of Custom-Made Porous Hydroxyapatite Cranioplasty: A Multicentric Cohort Study” [1] is aimed to demonstrate the efficacy of the 20-years of experience in cranioplasty using custom-made implants made of 3D porous HA saturated with Rifampin in an attempt to prevent early implant infections.
The authors compare the population of cranioplasties without preoperative antibiotic elution and those with a non-standardised antibiotic elution.

A total of 77 cranioplasties were included in the study, along with 120 retrospective cases in comparison.
Infections occurred in 2.6% of cranioplasties with antibiotic immersion compared to 7.8% of cranioplasties without.
These results further support the hypothesis that pre-treatment of 3D porous HA implants with antibiotic appears to prevent cranioplasty infections and could be a viable option to improve cranioplasty outcomes in the future, without forgetting the association with antibiotics in the treatment of late infections [2,3].

References:
[1] F. Amendola; L. Vaienti; R. Carbonaro; A. Nataloni; A. Barbanera; N. Zingaretti; P.C. Parodi; B. Zanotti “The Antibiotic Immersion of Custom-Made Porous Hydroxyapatite Cranioplasty: A Multicentric Cohort Study” - J Craniofac Surg 2022;33: 1464–1468 https://pubmed.ncbi.nlm.nih.gov/35165242/
[2] B. Zanotti; N. Zingaretti; A. Verlicchi; A. Alfieri; P.C. Parodi: “Successful Strategies for Dealing with Infected, Custom-made Hydroxyapatite Cranioplasty”. Journal of Craniofacial Surgery. 2018 Mar 1. doi: 0.1097/SCS.0000000000004415. 2018 https://www.ncbi.nlm.nih.gov/pubmed/29498974
[3] C. Iaccarino; PP Mattogni; B. Zanotti; S. Bellochi; A. Verlicchi; E. Viaroli; G. Pastorello; F. Sgulò; R. Ghardirpour; F. Servadei: “Septic complication following porous hydroxyapatite cranioplasty: prosthesis retention management” Journal of Neurosurgical Sciences. 2016 http://www.ncbi.nlm.nih.gov/pubmed/27175619

read more ›
  • previous news
  • ‹back to the archive
  • next news
Trauma Meeting 2023
28.09.23  Congress

Trauma Meeting 2023

read the news ›
EUROSPINE 2023
27.09.23  International congress

EUROSPINE 2023

read the news ›
Eans 2023
22.09.23  International congress

Eans 2023

read the news ›
Recent clinical paper
13.09.23  Message intended for healthcare professionals only

Recent clinical paper

read the news ›
ICRS 2023
29.08.23  International congress

ICRS 2023

read the news ›
Finceramica newsletter
10.08.23  Message intended for healthcare professionals only

Finceramica newsletter

read the news ›
Maioregen Tribute
24.05.23  Events

Maioregen Tribute

read the news ›
SECURITY NOTICE Cross-border falsification of devices
15.03.22  Urgent alert

SECURITY NOTICE Cross-border falsification of devices

read the news ›
  • ‹
  • 1
  • 2
  • 3
  • 4
  • ›
  • ‹
  • 1
  • 2
  • 3
  • 4
  • ›
  • Finceramica
  • Company
  • Products & Services
  • Network
  • Case histories
  • Media
  • News
  • Contacts
  • Tampieri financial group
  • Tampieri vegetable oil
  • Tampieri green energy
  • Faenza depurazioni
  • Tfc real estate
  • Helianthus green energy
  • Agf agrotrading
  • Tampieri Hungaria
  • Privacy / Cookies
  • Code of ethics
  • Conditions of sale
  • Credits
  • Tampieri © 2017
  • Fin-ceramica faenza spa
  • a Tampieri financial group spa
  • CF/PI e RI RA IT01025400399

This site uses cookies

Learn more